The Liver Meeting 2021-Hepatitis Debrief

Video Transcription

Video Summary

Dr. Carla Brady from Duke University provided a summary of the recent research on viral hepatitis at the liver meeting. She highlighted key studies on hepatitis C, focusing on progress towards the global goal of elimination by 2030. Challenges in diagnosis, treatment, and care cascade were discussed, along with innovative approaches like rapid treatment initiation for vulnerable populations. The presentation also covered studies on hepatitis B, including a cascade of care analysis and the use of new therapies like ASC22 and VIR2218. Additionally, outcomes in pregnancy for hepatitis B and C, as well as hepatitis D testing and treatment, were addressed. The need for improved screening, management, and access to care for viral hepatitis patients was emphasized throughout the summary.

Keywords

viral hepatitis

Dr. Carla Brady

Duke University

research

hepatitis C

hepatitis B